1. Home
  2. HWBK vs TNXP Comparison

HWBK vs TNXP Comparison

Compare HWBK & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HWBK

Hawthorn Bancshares Inc.

HOLD

Current Price

$33.25

Market Cap

238.2M

Sector

Finance

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$13.56

Market Cap

198.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWBK
TNXP
Founded
1865
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.2M
198.6M
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
HWBK
TNXP
Price
$33.25
$13.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.4K
364.8K
Earning Date
04-29-2026
05-11-2026
Dividend Yield
2.49%
N/A
EPS Growth
31.42
91.75
EPS
3.43
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
N/A
$558.11
Revenue Next Year
N/A
$38.29
P/E Ratio
$10.01
N/A
Revenue Growth
N/A
29.85
52 Week Low
$27.07
$11.60
52 Week High
$36.25
$69.65

Technical Indicators

Market Signals
Indicator
HWBK
TNXP
Relative Strength Index (RSI) 46.46 51.84
Support Level $32.90 $13.32
Resistance Level $34.10 $14.52
Average True Range (ATR) 0.90 0.74
MACD -0.10 0.03
Stochastic Oscillator 20.75 65.08

Price Performance

Historical Comparison
HWBK
TNXP

About HWBK Hawthorn Bancshares Inc.

Hawthorn Bancshares Inc is a financial holding company that, along with its subsidiary bank, provides commercial banking for small and mid sized businesses, including equipment, operating, commercial real estate and SBA loans, and personal banking services such as real estate mortgage lending, installment and consumer loans, certificates of deposit, and checking, savings and money market accounts. It has two segments, banking and wealth management, with the banking segment earning the majority of its revenue and conducting general banking business, offering checking and savings accounts, internet banking, debit cards, certificates of deposit, brokerage services and others. Its primary source of revenue is net interest income derived from lending and deposit taking activities.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Share on Social Networks: